You are here: All Products  > Livzon Mabpharm Leads $36 Million Funding of Epirus, a US Biosimilar Co.

Livzon Mabpharm Leads $36 Million Funding of Epirus, a US Biosimilar Co.

Price: $5.00
Available
Get instant access to this article for unlimited viewing and/or downloading for seven days.